FENC
Fennec Pharmaceuticals Inc
10.50$
-4.5%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +49.4% | +160.7% | -71.4% | -4.0% | +13.6% | +10.4% | +10.3% | +29.1% | +10.6% | +9.7% | +18.3% | – | |
| – | +106.9% | -19.7% | +10.5% | +123.2% | -50.7% | -44.2% | +159.2% | -31.7% | +167.3% | -67.7% | +26.5% | – | |
| – | +46.3% | +174.3% | -73.2% | -15.6% | +29.2% | +15.5% | +3.7% | +35.9% | +1.8% | +21.0% | +18.0% | – | |
| – | +166.7% | -90.6% | +5,133.3% | -38.2% | -48.5% | +88.0% | +13.8% | -72.9% | -31.0% | +145.0% | +140.8% | – | |
| – | +83.1% | -15.7% | +16.9% | -10.8% | -31.4% | +39.8% | +18.6% | -2.9% | +25.0% | -62.3% | +45.6% | – | |
| – | +50.9% | +2.0% | +5.5% | -7.3% | -24.2% | +12.0% | +24.1% | +5.1% | +21.6% | +0.4% | +5.2% | – | |
| – | – | – | -136.7% | – | – | – | – | – | – | – | – | – | |
| – | +6.9% | +13.0% | +3.2% | -3.9% | -5.8% | -37.6% | +2.3% | -5.0% | -47.4% | -97.7% | -57.1% | – | |
| – | – | – | -143.3% | – | – | – | – | – | – | – | +902.5% | – | |
| – | -100.0% | -72,300,100.0% | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | -143.3% | – | – | – | – | – | – | – | +881.6% | – | |
| – | – | – | -130.7% | – | – | – | – | – | – | – | +653.4% | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.